CognitiveIntranasal

Selank

Also known as: Tuftsin analog · TP-7

Heptapeptide tuftsin analog developed in Russia as a non-benzodiazepine anxiolytic. Modulates GABA receptor expression and enkephalin levels without sedation or dependence in animal studies.

At a glance

Half-life: 24 minutes
Common route: Intranasal
Typical dose range: 250–1,500mcg
Stability (reconstituted): 21days refrigerated

Best timing

Intranasal, 1–3x daily. Can be used acutely before stressful situations or on a fixed schedule.

Contraindications

Pregnancy
Concurrent benzodiazepine use without supervision

Watch symptoms

Mild sedation in first doses
Nasal irritation
Headache
Emotional blunting at higher doses

Citations

The primary literature.

01Selank: pharmacological action and the perspectives of its usePubMed
02Effect of the peptide Selank on the expression of GABA-receptor subunit genes in the rat hippocampusPubMed

Related protocols

Stacks that use Selank.

Cognitive Edge

Eight-week Semax-Selank rotation for focus, mood, and cognitive resilience.

View protocol

Back to library